Radiation therapy for breast cancer at the millennium

Radiotherapy and Oncology

Volumn 54, Issue 3, 2000, Pages 191-200

  Dobbs, H Jane ^a  

^a King's St Thomas' Cancer C ^*  (United Kingdom)

Author keywords

Breast cancer; Normal tissue complications; Radiation therapy

Indexed keywords

BRACHIAL PLEXUS INJURY; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; FEMALE; HEART DISEASE; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE IRRADIATION; NEUROPATHY; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SECOND CANCER;

EID: 0034162026     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(00)00137-7     Document Type: Article

References (49)

1. Bates T., Evans R.G. Audit of brachial plexus neuropathy following radiotherapy for breast carcinoma. Clin. Oncol. 7:(4):1995;236.
2. Bornstein B.A., Cheng C.W., Rhodes L.M., et al. Can simulation measurements be used to predict the irradiated lung volume in the tangential fields in patients treated for breast cancer? Int. J. Radiat. Oncol. Biol. Phys. 18:1990;181-187.
3. Cancer Guidance subgroup of the Clinical Outcomes Group. Improving outcomes in breast cancer: guidance for purchasers. Department of Health, London: NHS Executive 1996.
4. Canney P., Deehan C., Dickson J., Glegg M. Developments in radiotherapy. Cancer Treat. Rev. 23:1997;S23-S32.
5. Chen M.H., Chuang M.L., Bornstein B.A., Gelman R., Harris J.R., Manning W.J. Impact of respiratory manoeuvres on cardiac volume within left breast radiation portals. Circulation. 96:(10):1997;3269-3272.
6. Cowen D., Gonzague-Casabianca L., Brenot-Rossi I., et al. Thallium-201 Perfusion scintigraphy in the evaluation of late myocardial damage in left-sided breast cancer treated with adjuvant radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 41:1998;809-815.
7. Cuzick J., Stewart H., Rutqvist L., et al. Cause specific mortality in longterm survivors of breast cancer who participated in trials of radiotherapy. J. Clin. Oncol. 12:1994;447-453.
8. Das I.J., Cheng C.-W., Fein D.A., Fowble B. Patterns of dose variability in radiation prescription of breast cancer. Radiother. Oncol. 44:1997;83-89.
9. Dixon M. Sentinel node biopsy in breast cancer. Br. Med. J. 317:1998;295-296.
10. Early Breast Cancer Trialists' Collaborative Group, Polychemotherapy for early breast cancer: an overview of the randomised trials, Lancet 1998;352:930-942.
11. Evans P.M., Donovan E.M., Fenton N., et al. Practical implementation of compensators in breast radiotherapy. Radiother. Oncol. 49:1998;255-265.
12. Evans P.M., Hansen V.N., Mayles W.P.M., Swindell W., Torr M., Yarnold J.R. Design of compensators for breast radiotherapy using electronic portal imaging. Radiother. Oncol. 37:1995;43-54.
13. Fisher B., Anderson S., Redmond C.K., Wolmark N., Wickerham D.L., Cronin W.M. Reanalysis and results after 12 years of follow up in a randomised clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 22:1995;1456-1461.
14. Fuller S.A., Haybittle J.L., Smith R.E.A., Dobbs H.J. Cardiac doses in post-operative breast irradiation. Radiother. Oncol. 25:1992;19-24.
15. Gagliardi G., Lax I., Rutqvist L.E. Radiation therapy of Stage I Breast Cancer: analysis of treatment technique accuracy using three dimensional treatment planning tools. Radiother. Oncol. 24:(2):1992;94-101.
16. Gagliardi G., Lax I., Soderstrom S., Gyenes G., Rutqvist L.E. Prediction of excess risk of longterm cardiac mortality after radiotherapy of Stage I breast cancer. Radiother. Oncol. 46:(1):1998;63-71.
17. Goy J.C.M., Dobbs H.J., Henderson S., Humphreys S., Michell M.J. Variations in referral pattern for postoperative radiotherapy of patients with screen-detected breast cancer in the South Thames (East) Region. Clin. Oncol. 10:1998;24-29.
18. Grubbé E.H. Priority in the therapeutic use of X-Rays. Radiology. 1933;156-162.
19. Gyenes G., Fornander T., Carlens P., Glas U., Rutqvist L.E. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: A prospective study. Int. J. Rad. Oncol. Biol. Phys. 36:1996;899-905.
20. Haybittle J.L., Brinkley D., Houghton J., A'Hern R.P., Baum M. Post operative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. Br. Med. J. 298:1989;1611-1614.
21. Hayman J.A., Fairclough D.L., Harris J.R., Weeks J.C. Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy after conservative surgery for early stage breast cancer. J. Clin. Oncol. 15:(3):1997;1252-1260.
22. Holmberg O., Huizerga H., Idzes M.H.M., Lebesque J.V., Vijlbrief R.E., Mijnheer B.J. In vivo determination of the accuracy of field matching in breast cancer irradiation using an electronic portal imaging device. Radiother. Oncol. 33:1994;157-166.
23. Host H., Brennhovd M.D., Loeb M. Postoperative radiotherapy in breast cancer - longterm results from the Oslo study. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;727-732.
24. Idzes M.H., Holmberg O., Mijnheer B.J., Huizenga H. Effect of set up uncertainties on the dose distribution in the match region of supraclavicular and tangential breast fields. Radiother. Oncol. 46:(1):1998;91-98.
25. Johansen J., Bentzen S.M., Overgaard J., Overgaard M. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia and skin erythema after radiotherapy. Radiother. Oncol. 40:1996;101-109.
26. Karlsson P., Holmberg E., Johansson K.-A., Kindblom L.-G., Carstensen J., Wallgren A. Soft tissue sarcoma after treatment for breast cancer. Radiother. Oncol. 38:1996;25-31.
27. Keshtgar M.R.S., Ell P.J. Sentinel lymph node detection and imaging. Eur. J. Nucl. Med. 26:1999;57-67.
28. Landberg T., Chavaudra J., Dobbs H.J., et al. ICRU Report 62. Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50) International Commission on Radiotherapy Units and Measurements. 1999.
29. Lind P.A.R.M., Rosfors S., Wennberg B., Glas U., Bevegard S., Fornander T. Pulmonary function following adjuvant chemotherapy and radiotherapy for breast cancer and the issue of three-dimensional treatment planning. Radiother. Oncol. 49:1998;245-254.
30. Magee B., Coyle C., Kirby M.C., Kane B., Williams P.C. Use of electronic portal imaging to assess cardiac irradiation in breast radiotherapy. Clin. Oncol. 9:(4):1997;259-261.
31. Marshall M.G. Three field isocentric breast irradiation using asymmetric jaws and a tilt board. Radiother. Oncol. 28:1993;228-232.
32. Mitine C., Dutreix A., Van der Scheuren E. Tangential breast irradiation: influence of technique set up on transfer errors and reproducibility. Radiother. Oncol. 22:1991;308-310.
33. Moody A.M., Mayles W.P.M., Bliss J.M., et al. The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother. Oncol. 33:1994;106-112.
34. Neal A.J., Torr M., Helyer S., Yarnold J.R. Correlation of breast dose heterogeneity with breast size using 3D CT planning and dose-volume histograms. Radiother. Oncol. 34:1995;210-218.
35. Neal A.J., Yarnold J.R. Estimating the volume of lung irradiated during tangential breast irradiation using the central lung distance. Br. J. Radiol. 68:(813):1995;1004-1008.
36. Olsen N.K., Pfeiffer P., Johannsen L., Schroder H., Rose C. Radiation-induced brachial plexopathy: Neurological follow up in 161 recurrence-free breast cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 26:1993;43-49.
37. Overgaard M., Hansen P.S., Overgaard J., et al. The Danish Breast Cancer Cooperative Group 82b Trial. Postoperative radiotherapy in high risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N. Engl. J. Med. 337:(14):1997;949-955.
38. Ragaz J., Jackson S.M., Le N., Plenderleith I.H., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N. Engl. J. Med. 337:(14):1997;956-962.
39. Rosenow U.F., Valentine E.S., Davis L.W. A technique for treating local breast cancer using a single set up point and asymmetric collimation. Int. J. Radiat. Onc. Biol. Phys. 19:1990;183-188.
40. Rutqvist L.E., Liedberg A., Hammar N., Dalberg K. Myocardial infarction among women with early stage breast cancer treated with conservative surgery and breast irradiation. Int. J. Radiat. Oncol. Biol. Phys. 40:(2):1998;359-363.
41. START Trial (Standardisation of Breast Radiotherapy). A randomised comparison of fractionation regimens after local excision or mastectomy in women with early stagebreast cancer, Final Protocol, UKCCCR, July 1998.
42. Thilmann C., Adamietz I.A., Saran F., Mose S., Kostka A., Böttcher H.D. The use of a standardised positioning support cushion during daily routine of breast irradiation. Int. J. Radiat. Oncol. Biol. Phys. 41:1998;459-463.
43. Tucker S.L., Geara F.B., Peters L.J., Brock W.A. How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity? Radiother. Oncol. 38:1996;103-113.
44. Van Tienhoven G., Lanson J., Crabeels D., Heukelom S., Mijnheer B. Accuracy in tangential breast treatment set up: a portal imaging study. Radiother. Oncol. 22:1991;317-322.
45. Van Tienhoven G., Mijnheer B.J., Bartelink H., Gonzalez D.G. Quality assurance of the EORTC trial 22881/10882: "Boost vs. no boost in breast conserving therapy"; an overview. Strahlenther. Onkol. 173:1997;201-207.
46. Veronesi U., Paganelli G., Galimberti V., et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet. 349:1997;1864-1867.
47. Westbrook C., Gildersleve J., Yarnold J.R. Quality assurance in daily treatment procedure: patient movement during tangential field treatment. Radiother. Oncol. 22:1991;299-303.
48. th International Conference on the Use of Computers in Radiation Therapy. 1997.
49. Yu C.X., Jaffray D.A., Wong J.W. The effects of intrafraction organ motion on the delivery of dynamic intensity modulation. Phys. Med. Biol. 43:1998;91-104.